87 related articles for article (PubMed ID: 18097550)
1. GSH loss per se does not affect neuroblastoma survival and is not genotoxic.
Marengo B; Balbis E; Patriarca S; De Ciucis C; Furfaro A; Nitti M; Marinari UM; Pronzato MA; Traverso N; Domenicotti C
Int J Oncol; 2008 Jan; 32(1):121-7. PubMed ID: 18097550
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma.
Marengo B; De Ciucis C; Verzola D; Pistoia V; Raffaghello L; Patriarca S; Balbis E; Traverso N; Cottalasso D; Pronzato MA; Marinari UM; Domenicotti C
Free Radic Biol Med; 2008 Feb; 44(3):474-82. PubMed ID: 17991446
[TBL] [Abstract][Full Text] [Related]
3. Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1.
Furfaro AL; Macay JR; Marengo B; Nitti M; Parodi A; Fenoglio D; Marinari UM; Pronzato MA; Domenicotti C; Traverso N
Free Radic Biol Med; 2012 Jan; 52(2):488-96. PubMed ID: 22142473
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
5. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
Cuperus R; van Kuilenburg AB; Leen R; Bras J; Caron HN; Tytgat GA
Free Radic Biol Med; 2011 Sep; 51(6):1213-20. PubMed ID: 21741474
[TBL] [Abstract][Full Text] [Related]
6. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.
Anderson CP; Tsai JM; Meek WE; Liu RM; Tang Y; Forman HJ; Reynolds CP
Exp Cell Res; 1999 Jan; 246(1):183-92. PubMed ID: 9882527
[TBL] [Abstract][Full Text] [Related]
7. PKCδ sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage.
Marengo B; De Ciucis C; Ricciarelli R; Passalacqua M; Nitti M; Zingg JM; Marinari UM; Pronzato MA; Domenicotti C
PLoS One; 2011 Feb; 6(2):e14661. PubMed ID: 21326872
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E, γ-tocotrienol, Protects Against Buthionine Sulfoximine-Induced Cell Death by Scavenging Free Radicals in SH-SY5Y Neuroblastoma Cells.
Tan JK; Then SM; Mazlan M; Jamal R; Ngah WZ
Nutr Cancer; 2016; 68(3):507-17. PubMed ID: 27008382
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
Anderson CP; Reynolds CP
Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
[TBL] [Abstract][Full Text] [Related]
10. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
[TBL] [Abstract][Full Text] [Related]
11. HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
Furfaro AL; Piras S; Passalacqua M; Domenicotti C; Parodi A; Fenoglio D; Pronzato MA; Marinari UM; Moretta L; Traverso N; Nitti M
Biochim Biophys Acta; 2014 Apr; 1842(4):613-22. PubMed ID: 24380881
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
Lee HM; Kim DH; Lee HL; Cha B; Kang DH; Jeong YI
Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
[TBL] [Abstract][Full Text] [Related]
13. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma.
Colla R; Izzotti A; De Ciucis C; Fenoglio D; Ravera S; Speciale A; Ricciarelli R; Furfaro AL; Pulliero A; Passalacqua M; Traverso N; Pronzato MA; Domenicotti C; Marengo B
Oncotarget; 2016 Oct; 7(43):70715-70737. PubMed ID: 27683112
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol modulates GSH system in C6 astroglial cells through heme oxygenase 1 pathway.
Arús BA; Souza DG; Bellaver B; Souza DO; Gonçalves CA; Quincozes-Santos A; Bobermin LD
Mol Cell Biochem; 2017 Apr; 428(1-2):67-77. PubMed ID: 28070834
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of energy and redox states in the C6 glioma cells by buthionine sulfoxamine and N-acetylcysteine and the effect on cell survival to cadmium toxicity.
Yang MS; Yu LC; Pat SW
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):56-61. PubMed ID: 17519112
[TBL] [Abstract][Full Text] [Related]
17. Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.
Anderson CP; Seeger RC; Satake N; Monforte-Munoz HL; Keshelava N; Bailey HH; Reynolds CP
J Pediatr Hematol Oncol; 2001 Nov; 23(8):500-5. PubMed ID: 11878777
[TBL] [Abstract][Full Text] [Related]
18. The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO).
Chen J; Small-Howard A; Yin A; Berry MJ
BMC Neurosci; 2005 Feb; 6():10. PubMed ID: 15707499
[TBL] [Abstract][Full Text] [Related]
19. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis.
Stokes AH; Lewis DY; Lash LH; Jerome WG; Grant KW; Aschner M; Vrana KE
Brain Res; 2000 Mar; 858(1):1-8. PubMed ID: 10700589
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection against neuroblastoma cell death induced by depletion of mitochondrial glutathione.
Dukhande VV; Kawikova I; Bothwell AL; Lai JC
Apoptosis; 2013 Jun; 18(6):702-12. PubMed ID: 23494481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
